What's New Archives

2009

FDA Psychopharmacologic Drugs Advisory Committee to consider new drug applications (NDAs) for selected agents to treat schizophrenia, bipolar mania, and manic/mixed episodes associated with bipolar disorder in children more

Interim Guidance for Clinicians on the Prevention and Treatment of Novel Influenza A (H1N1) Influenza Virus Infection in Infants and Children (CDC) more

Letter to Health Care Professionals from the Food and Drug Administration (FDA) regarding the H1N1 Flu
Virus more

HHS Declares Public Health Emergency for Swine Flu more

New pediatric information available for 32 products more

The MTA at 8 Years: Prospective follow-up of children treated for combined type ADHD in the multisite study more

President Obama Announces Key FDA Appointments: Dr Margaret Hamburg named as FDA Commissioner and Dr Joshua Sharfstein, MD, FAAP, as Principal Deputy Commissioner more

USP Issues Call for Candidates: Nominees Sought for Service on Expert Committees/Panels more

FDA Launches SAFEKIDS Initiative with Academic and Clinical Partners
Public-Private Partnership will assess safety of anesthetics and sedatives in young children more

Industry Guidance: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices more

FDA Seeks Public Comments on Issues Related to the Enrollment of Certain Populations in Clinical Drug
Trials more

2008

FDA Advisory Committees to Consider Benefit Risk Assessment of Long-Acting Beta-2 Adrenergic Agonists for the Treatment of Asthma in Adults and
Children more

NICHD Releases RFA - Pediatric Pharmacology and Therapeutics Research Consortium more

FDA Statement Following CHPA's Announcement on Nonprescription Over-the-Counter Cough and Cold Medicines in Children more

Manufacturers of Oral OTC Pediatric Cough and Cold Medicines Announce Plan to Transition Product Labeling more

FDA to Convene Public Hearing on Over-the-Counter (OTC) Cough and Cold Medications for Pediatric Use more

Update from CDC and FDA on the Safety of Gardasil Vaccine more

New AAP Policy Statement Addresses Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder more

New program supports physicians transition from paper-based to electronic prescribing more

AAP Releases New Clinical Report: Preparing for Pediatric Emergencies: Drugs to Consider more

FDA Releases Advisory Concerning Use of Over-the-Counter Cough and Cold Products more

2007

DEA Publishes Final Rule Regarding Issuance of Multiple Prescriptions for
Schedule II Controlled Substances more

AAP Testimony to the FDA Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee Regarding the Use of Cough & Cold Products in Children more

Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines more

FDA Releases Briefing Information for the October 18-19, 2007 Joint Meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee Regarding Use of Cough and Cold Products in Children more

President Bush Signs H.R. 3580, the "Food and Drug Administration Amendments of 2007" more

Slone Survey Report: Patterns of Medication Use in the United States, 2006 more

News Release:  Pediatricians Applaud Pediatric Drug, Device Legislation Passage more

Press Statement on House Pediatric Drug Legislation - By Jay E. Berkelhamer, MD, FAAP, AAP President more

FDA issues Public Health Advisory on the Use of Nonprescription Cough and Cold Products in Children more

AAP Testimony presented before the House Committee on Energy and Commerce Subcommittee on Health regarding the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

U.S. Reviewing Safety of Children's Cough Drugs (New York Times, March 2, 2007) more

2006

New Report on Sedation Monitoring and Management Released by AAP and the American Academy of Pediatric Dentistry more

Academy endorses principles for sound drug formularies more

AAP/COID releases new policy on The Use of Systemic Fluroquinolones more

AAP offers evidence-based recommendations for diagnosing, treating bronchiolitis in infants more

AHRQ seeks nominations for Effective Health Care Stakeholder Group more

FDA Panel recommends black box warning on ADHD stimulant medications more

Delphi Survey Executive Summary more

Issues Surrounding Pediatric Drug Labeling - Read the Executive Summary of Periodic Survey #62 more

AAP Testimony on ADHD Medications presented to the FDA Pediatric Advisory Committee, March 22, 2006 more

Questions and Answers: Safety of Pills for Treating ADHD - Common questions from parents more

2005

FDA Joins Children's Health Groups to Mark Historic Milestone for Pediatric Drugs - 100 Drug Labels Have New Pediatric Information Since 1997 more